13-102730060-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001146197.3(CCDC168):c.20637G>T(p.Leu6879Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,551,264 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001146197.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC168 | NM_001146197.3 | c.20637G>T | p.Leu6879Phe | missense_variant | 4/4 | ENST00000322527.4 | NP_001139669.1 | |
CCDC168 | XM_011521106.2 | c.20517G>T | p.Leu6839Phe | missense_variant | 5/5 | XP_011519408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC168 | ENST00000322527.4 | c.20637G>T | p.Leu6879Phe | missense_variant | 4/4 | 3 | NM_001146197.3 | ENSP00000320232.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000160 AC: 25AN: 156254Hom.: 1 AF XY: 0.000157 AC XY: 13AN XY: 82702
GnomAD4 exome AF: 0.0000207 AC: 29AN: 1399104Hom.: 1 Cov.: 33 AF XY: 0.0000188 AC XY: 13AN XY: 690068
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | The c.20637G>T (p.L6879F) alteration is located in exon 4 (coding exon 4) of the CCDC168 gene. This alteration results from a G to T substitution at nucleotide position 20637, causing the leucine (L) at amino acid position 6879 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at